California Innovation Fund

California Innovation Fund is a venture capital firm that invests in high-potential startups emerging from UC Berkeley and peer entrepreneurial universities globally. The firm aims to provide capital, expertise, and a supportive community to transform breakthrough innovations into high-impact companies. It distinguishes itself by reinvesting a portion of its profits back into the University of California system, fostering a virtuous cycle that supports public education and fuels the next generation of entrepreneurs.

The firm launched its first fund, California Innovation Fund I, in 2021, which has since made investments in 27 companies within the University of California ecosystem. Building on this foundation, California Innovation Fund II is scheduled for launch in 2026. This upcoming fund seeks to replicate and expand upon the success of its predecessor, broadening its deal flow pipeline to include additional robust university entrepreneurship ecosystems with ties to UC Berkeley and its team members, notably the Technical University of Munich and its affiliated Center for Digital Technology & Management.

California Innovation Fund employs a rigorous investment process that begins with sourcing opportunities through its on-campus presence and relationships with various incubators, accelerators, and entrepreneurship courses. A four-phase due diligence process evaluates technology, market size, founder capabilities, and valuation, often leveraging the expertise of professors and limited partners. Post-investment, the firm provides comprehensive stewardship, offering operating knowledge, wide-ranging industry expertise, executive coaching, and connections to on-campus resources. The fund primarily targets Seed and Series A rounds, but also maintains an opportunistic mandate for select later-stage investments. Portfolio companies mentioned in various sources include Modelwise, TransCrypts, Your360 AI, SixMap, MIIST Therapeutics, CatenaBio, FreeWire, Windfall Data, Kyte, Engage Bio, Synvivia, Calyx, and Selva Therapeutics, spanning sectors such as Business/Productivity Software, Technology, Biotechnology, and Financial Services.

The team at California Innovation Fund is characterized by its deep roots in the UC Berkeley ecosystem and an expanding international presence, particularly in Germany. Dr. Kurt Beyer, the Founder and General Partner, is a UC Berkeley PhD alumnus with extensive experience in entrepreneurship, angel investing, and institutional investment. Bryce Gilleland serves as a General Partner, bringing a background in finance and the energy industry. Managing Partners include Dr. Anne Greul, a behavioral economist with experience at Audi and McKinsey, and Dr. Caspar Schauseil, a serial entrepreneur with a history at Amazon and in M&A advisory. Shiva Somasundaram, another Managing Partner, contributes over a decade of experience in AI and Machine Learning. Mark Jones and Jerry Bellman also serve as Managing Partners, providing expertise in legal and financial leadership, respectively. This diverse team offers founders deep experience, mentorship, and extensive networks across various sectors and geographies.